Le Lézard
Classified in: Health, Science and technology
Subjects: SVY, TRI, MIN

Pack Health Publishes Prostate Cancer Research in JCO Oncology Practice


The research found that digital health coaching could provide a new opportunity for those with prostate cancer to manage their condition.

BIRMINGHAM, Ala. , May 4, 2022 /PRNewswire/ -- Leading patient engagement platform, Pack Health, today announced the publication of their recent study manuscript, "A Pilot Feasibility Study of Digital Health Coaching for Men with Prostate Cancer" in the Journal of Clinical Oncology (JCO) Oncology Practice. Pack Health collaborated with the Sidney Kimmel Cancer Center ? Jefferson Health (SKCC) on this research. The study detailed in the publication examined the feasibility of digital health coaching (DHC) for men undergoing treatment for prostate cancer within an ambulatory setting.

Individuals with prostate cancer can experience challenges while managing their diagnosis and treatment within the community setting, including discussing potentially sensitive topics with their care team. Prior research suggests that digital health coaching is a viable intervention for patients with cancer diagnoses to measure patient-reported outcomes, address patient self-efficacy, and work beyond ambulatory settings.

A total of 100 men, age 18 and older, living within the greater Philadelphia area received 12 weeks of access to a digital health coaching program developed for individuals with prostate cancer immediately following enrollment. In order to be eligible, participants must have actively received treatment for a prostate cancer diagnosis within the past two years. The program included access to a Health Advisor from Pack Health. Participants and their Health Advisors spoke weekly by phone call, text, or email to discuss topics related to prostate cancer care, including fatigue, pain management, sexual health, and stress and anxiety.

Feasibility of the digital health coaching intervention was achieved with 63 of the 88 eligible participants who enrolled completing the program (71.5%). Additional outcome measures also demonstrated improvement in other areas, including health self-efficacy and physical health.

"This research suggests that digital health coaching could be a promising patient support intervention to enhance outcomes for men with prostate cancer during and beyond the treatment period. We are grateful to work with our collaborators at Jefferson Health and to those men who consented to participate in this study, without whom these insights would not have been possible," says Kelly Brassil, Ph.D., R.N., F.A.A.N., Director of Clinical Research at Pack Health.

About Pack Health
Pack Health is an evidence-based patient engagement platform that helps change health behaviors to close gaps in care and improve outcomes. Pack Health comprehensively addresses chronic conditions, comorbidities, social determinants, and barriers. The model is proven to drive results across industries, including life sciences, health plans, and research. For more information, visit www.packhealth.com.

In 2022, Pack Health was acquired by Quest Diagnostics, the nation's leading provider of diagnostic information services. Pack Health is part of Quest's Extended Care portfolio of services designed to facilitate access to care beyond traditional healthcare settings. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States.

Pack Health is intended to be an aid for people to gain insights into ways to help improve their general health and well-being.

Learn more at http://www.packhealth.com/.

Contact: Brittney Vigna, Director of Marketing, Pack Health, [email protected]

PRESS CONTACT

NAME
Brittney Vigna
PHONE
855-255-2362
WEBSITE 
https://packhealth.com/

SOURCE Pack Health


These press releases may also interest you

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: